Business

Pharma Innovation Criticism

Updated 2026-05-26 08:35 UTC 1 source Negative

Tahir Amin and Rohit Malpani argue in their opinion piece that pharmaceutical companies often misuse the term 'innovation' to maintain monopolies. They suggest that not all investments result in novel inventions.

Coverage timeline — 1 article

STAT News

Opinion: The innovation trap: How pharma weaponizes a word to extend monopolies

“Just because a company invests does not mean it has invented anything novel,” Tahir Amin and Rohit Malpani write in this excerpt from “Pharma Monopoly.”

2026-05-26 08:30 UTC